These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 19224250

  • 1. Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.
    Akman S, Kalay S, Akkaya B, Koyun M, Akbaş H, Baysal YE, Guven AG.
    Pediatr Nephrol; 2009 Jun; 24(6):1173-80. PubMed ID: 19224250
    [Abstract] [Full Text] [Related]

  • 2. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.
    Ots M, Mackenzie HS, Troy JL, Rennke HG, Brenner BM.
    J Am Soc Nephrol; 1998 Feb; 9(2):224-30. PubMed ID: 9527398
    [Abstract] [Full Text] [Related]

  • 3. [Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Cas Lek Cesk; 1999 Oct 20; 138(18):560-4. PubMed ID: 10596472
    [Abstract] [Full Text] [Related]

  • 4. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z.
    Am J Physiol Renal Physiol; 2005 Oct 20; 289(4):F880-90. PubMed ID: 15942045
    [Abstract] [Full Text] [Related]

  • 5. Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
    Renke M, Tylicki L, Rutkowski P, Rutkowski B.
    Scand J Urol Nephrol; 2004 Oct 20; 38(5):427-33. PubMed ID: 15764256
    [Abstract] [Full Text] [Related]

  • 6. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
    Tylicki L, Rutkowski P, Renke M, Rutkowski B.
    Am J Nephrol; 2002 Oct 20; 22(4):356-62. PubMed ID: 12169868
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of losartan in patients with primary focal segmental glomerulosclerosis resistant to immunosuppressive treatment.
    Usta M, Ersoy A, Dilek K, Ozdemir B, Yavuz M, Güllülü M, Yurtkuran M.
    J Intern Med; 2003 Mar 20; 253(3):329-34. PubMed ID: 12603500
    [Abstract] [Full Text] [Related]

  • 8. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
    Mackie FE, Meyer TW, Campbell DJ.
    Kidney Int; 2002 Feb 20; 61(2):555-63. PubMed ID: 11849396
    [Abstract] [Full Text] [Related]

  • 9. Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
    Tesar V, Zima T, Jirsa M, Crkovská J, Stípek S, Vernerová Z, Seráková M.
    Med Sci Monit; 2002 Feb 20; 8(2):BR69-74. PubMed ID: 11859270
    [Abstract] [Full Text] [Related]

  • 10. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
    Tanaka H, Suzuki K, Nakahata T, Tsugawa K, Konno Y, Tsuruga K, Ito E, Waga S.
    Pediatr Int; 2004 Oct 20; 46(5):576-9. PubMed ID: 15491387
    [Abstract] [Full Text] [Related]

  • 11. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
    Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM.
    Am J Kidney Dis; 2001 Jul 20; 38(1):18-25. PubMed ID: 11431176
    [Abstract] [Full Text] [Related]

  • 12. Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
    Blezer EL, Nicolay K, Koomans HA, Joles JA.
    Am J Hypertens; 2001 Jan 20; 14(1):54-61. PubMed ID: 11206680
    [Abstract] [Full Text] [Related]

  • 13. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Tancharoen W, Pattaragarn A, Sumboonnanonda A.
    Pediatr Int; 2012 Dec 20; 54(6):793-7. PubMed ID: 22621380
    [Abstract] [Full Text] [Related]

  • 14. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome.
    Liern M, Colazo A, Vallejo G, Zotta E.
    Nefrologia (Engl Ed); 2021 Dec 20; 41(3):304-310. PubMed ID: 36166246
    [Abstract] [Full Text] [Related]

  • 15. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Proesmans W, Van Dyck M, Devriendt K.
    Nephrol Dial Transplant; 2009 Apr 20; 24(4):1335-8. PubMed ID: 19147669
    [Abstract] [Full Text] [Related]

  • 16. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
    Jovanović DB, Jovović Dj, Varagić J, Dimitrijević J, Dragojlović Z, Djukanović L.
    Srp Arh Celok Lek; 2002 Apr 20; 130(3-4):73-80. PubMed ID: 12154518
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
    Peters H, Border WA, Noble NA.
    Kidney Int; 2000 Apr 20; 57(4):1493-501. PubMed ID: 10760085
    [Abstract] [Full Text] [Related]

  • 18. Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes.
    Cetinkaya R, Odabas AR, Selcuk Y.
    Int J Clin Pract; 2004 May 20; 58(5):432-5. PubMed ID: 15206496
    [Abstract] [Full Text] [Related]

  • 19. Effect of losartan treatment on the proteinuria in normotensive patients having proteinuria due to secondary amyloidosis.
    Odabas AR, Cetinkaya R, Selcuk Y, Bilen H.
    Ups J Med Sci; 2001 May 20; 106(3):183-8. PubMed ID: 12166510
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G, Filiopoulos V, Georgoulias C, Tentolouris N, Michail S.
    Scand J Urol Nephrol; 2010 Sep 20; 44(4):251-6. PubMed ID: 20201749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.